BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34058209)

  • 1. Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer.
    Hanafy NAN
    Int J Biol Macromol; 2021 Jul; 182():1981-1993. PubMed ID: 34058209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
    Lee WH; Loo CY; Rohanizadeh R
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
    Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan coordination driven self-assembly for effective delivery of curcumin.
    Liang H; Sun X; Gao J; Zhou B
    Int J Biol Macromol; 2020 Dec; 165(Pt B):2267-2274. PubMed ID: 33098899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
    Wang F; Yang Y; Ju X; Udenigwe CC; He R
    J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application.
    Esfandiarpour-Boroujeni S; Bagheri-Khoulenjani S; Mirzadeh H; Amanpour S
    Carbohydr Polym; 2017 Jul; 168():14-21. PubMed ID: 28457434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer.
    Mahalunkar S; Yadav AS; Gorain M; Pawar V; Braathen R; Weiss S; Bogen B; Gosavi SW; Kundu GC
    Int J Nanomedicine; 2019; 14():8285-8302. PubMed ID: 31802866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
    Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
    Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel magneto-responsive nanoplatforms based on MnFe
    Jardim KV; Palomec-Garfias AF; Andrade BYG; Chaker JA; Báo SN; Márquez-Beltrán C; Moya SE; Parize AL; Sousa MH
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():184-195. PubMed ID: 30184741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
    Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
    Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity Effects of Curcumin Loaded on Chitosan Alginate Nanospheres on the KMBC-10 Spheroids Cell Line.
    Afzali E; Eslaminejad T; Yazdi Rouholamini SE; Shahrokhi-Farjah M; Ansari M
    Int J Nanomedicine; 2021; 16():579-589. PubMed ID: 33531802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis and characterization of targeted delivery curcumin using chitosan-magnetite-reduced graphene oxide as nano-carrier.
    Kazemi S; Pourmadadi M; Yazdian F; Ghadami A
    Int J Biol Macromol; 2021 Sep; 186():554-562. PubMed ID: 34216673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
    Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
    Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
    Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH and near-infrared active; chitosan-coated halloysite nanotubes loaded with curcumin-Au hybrid nanoparticles for cancer drug delivery.
    Rao KM; Kumar A; Suneetha M; Han SS
    Int J Biol Macromol; 2018 Jun; 112():119-125. PubMed ID: 29378273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-modified carboxymethyl chitosan-based drug delivery system for breast cancer specific combination therapy via regulating mitochondrial calcium concentration.
    Lv Y; Chen X; Shen Y
    Carbohydr Polym; 2024 Jan; 323():121434. PubMed ID: 37940300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanohybrid Based on (Mn, Zn) Ferrite Nanoparticles Functionalized With Chitosan and Sodium Alginate for Loading of Curcumin Against Human Breast Cancer Cells.
    Ahmadi F; Saeedi M; Akbari J; Seyedabadi M; Ebrahimnejad P; Morteza-Semnani K; Ghasemi S; Moalem-Banhangi M; Babaei A; Hashemi SMH; Asare-Addo K; Nokhodchi A
    AAPS PharmSciTech; 2023 Nov; 24(8):222. PubMed ID: 37935931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.